Regal Healthcare Capital Partners
One Penn Plaza, Suite 4610, New York, NY, 10119, United States
Overview
Regal Healthcare Capital Partners is an investment Firm.They seek to partner with leading edge entrepreneurs that will benefit from the strategic, financial, operational and managerial expertise our team can bring to their growing business. Through genuine collaboration we want to understand every aspect of your business and help create a roadmap to success.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 2
Sector focus
- Venture Capital
Investment portfolio
- Extend Fertility
Led · Series A · Feb 2019
Extend Fertility operates a purpose-built, egg-freezing-first clinic and cryopreservation lab and also provides infertility treatments such as in vitro fertilization (IVF) and intrauterine insemination (IUI). The company completed 1,000 egg-freezing cycles in 2018 in its New York lab. It positions itself as lower-cost than legacy providers, charging $5,500 for one egg-freezing cycle and $4,000 for additional cycles; medication costs typically run $2,000–$5,000 and are paid through third parties. Most of Extend’s services do not accept insurance, consistent with broader fertility-care coverage gaps. The company emphasizes a modern, state-of-the-art lab and workflows designed specifically for egg freezing rather than being retrofitted from legacy infertility providers. Leadership changes include the appointment of Anne Hogarty as CEO while co-founder Ilaina Edison remains on the board.